COVID hospitalizations soar by 330% in region where Omicron first detected
Health experts warn coronavirus vaccine will be less effective against the new variant. Pfizer begins work on dose better suited ...
Israel Hayom is a media organization founded on the belief that the Israeli public deserves better journalism—more balanced, more accurate, and more reliable. Journalism that speaks rather than shouts. Journalism that is trustworthy, objective, and matter-of-fact. A different kind of journalism, offered free of charge. The first print edition was published on July 30, 2007, and in 2010 Israel Hayom became the Israeli newspaper with the highest weekday readership. The newspaper’s publisher is Dr. Miriam Adelson. Its Editor-in-Chief is Omar Lachmanovitch, and its founding editor is Amos Regev. Israel Hayom’s Hebrew and English websites, as well as its Android and iOS applications, provide around-the-clock news coverage, exclusive content, breaking news and updates, analysis and commentary, video, podcasts, and live broadcasts. The digital platforms of Israel Hayom include news and opinion channels covering culture and entertainment, lifestyle, technology, sports, business and consumer affairs, health, military affairs, food, Judaism, tourism, and automobiles. In 2021, a new Hebrew-language website and mobile application were launched to provide users with a fast, up-to-date, secure, and convenient experience. The content of the newspaper’s print edition is also available online through a daily digital edition and can be received via newsletter. “The Israel Hayom Clique,” the publication’s exclusive benefits club, offers website users discounts and special promotions on products and services. Israel Hayom welcomes feedback, criticism, and suggestions for improvement from its readers. You can contact the organization by email at hayom@israelhayom.co.il
Health experts warn coronavirus vaccine will be less effective against the new variant. Pfizer begins work on dose better suited ...
Health officials hope data on Israeli military personnel will help clarify the risk of heart muscle inflammation in younger people ...
Dr. Tal Zaks, the man behind the Moderna vaccine, shares with Israel Hayom how he oversaw the development of the ...
After heading Moderna's coronavirus vaccine development, Dr. Tal Zaks is ready to tackle new challenges at Israel's Teva Pharmaceuticals.
Stephane Bancel explains that based on vaccine production rates, everyone on earth will have access to doses within the next ...
With FDA approval expected in coming weeks, Israeli Pediatric Association president says proving efficacy and safety of vaccine in this age ...
The decision comes hours after a special advisory panel recommended Israel start giving a booster shot to mitigate waning antibody ...
Health minister: Immunocompromised to be eligible for third booster dose of COVID vaccine. With infections among children on the rise, ...
To bridge the supply gap, the Health Ministry will continue to administer second doses using the Moderna vaccine. It also ...
Pfizer says its vaccine is safe, effective and produces robust antibody responses in 12- to 15-year-olds.
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]